Madrigal's $600M offering; PureTech to return $100M to shareholders
Plus, news about Outlook Therapeutics, Geron, Fate Therapeutics, Enliven Therapeutics, Seelos and Portal Biotechnologies:
Madrigal Pharmaceuticals’s $600M offering: The company is raising money to boost …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.